Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden
PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
Zidavi is recommended by the Infectious Disease Society of America
Subject Expert Committee(SEC) of Central Drugs Standard Control Organization (CDSCO)
Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
Younger Indians have a 10 times higher rate of heart attack
Brings 25 years of global operations and supply chain experience to Piramal
V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)